Illuminating the Immune System
News May 01, 2013
A team led by Ruslan Medzhitov, professor of immunobiology and a Howard Hughes Medical Institute investigator, found that the body’s ability to tolerate infectious disease pathogens is as important as the immune system’s ability to fight them.
The team’s research, published in Science Express, explored the balance between tolerance and immune response in mice infected with both the influenza virus and legionella pneumophila bacteria, which cause pneumonia. When the mice were given a dose of either the virus or bacteria alone, their bodies fought the infection, and they survived. But when they were given the same doses of both virus and bacteria within three days, and when they received the virus first, all of the mice died. A longer time between the infective disease allowed the mice to survive the subsequent bacterial infection.
Another team led by Richard Flavell, chair and professor of immunobiology, and published in the journal Nature Medicine, discovered markers for the cellular mechanism that can shut down the immune response, leading to diseases that based on immunodeficiency. This finding will help further the understanding of the role of immunosuppression in human disease.
British Pharmacological Society’s Drug Discovery of the Year 2018 AnnouncedNews
A new medicine used to treat an ultra-rare inherited disorder which leaves babies without a fully functioning immune system has been named the British Pharmacological Society’s Drug Discovery of the Year 2018.READ MORE
What Does the Future of Vaccines and Immunotherapy Look Like?News
Innovative biomaterials could enhance vaccines against HIV and other infectious diseases and immunotherapies for patients with cancer or dampen responses in autoimmune disorders, allergies and transplanted organ recipients. A review of these efforts was recently released.READ MORE
CMC Biologics Announces Development and Manufacturing Agreement with Harpoon TherapeuticsNews
Companies have entered into agreement for the development and manufacturing of three TriTAC molecules for the treatment of cancers.READ MORE